Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of BIBF 1120 in Recurrent Glioblastoma Multiforme

NCT01251484 is registered in ClinicalTrials.gov with Ulrik Lassen as lead sponsor.

NCT NCT01251484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01251484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of BIBF 1120 in Recurrent Glioblastoma Multiforme
Lead sponsor
Ulrik Lassen
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2011
Completion date
August 31, 2012
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent glioblastoma